Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Witzel

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Neurobiology of Aging|August 6, 2022
Fast versus slow disease progression in amyotrophic lateral sclerosis-clinical and genetic factors at the edges of the survival spectrumSimon Witzel, Matias Wagner, Chen Zhao, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 20, 2021
Phenotyping of the thoracic-onset variant of amyotrophic lateral sclerosisKatharina Kandler, Simon Witzel, Konstantin Eder, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2024
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohortSimon Witzel, Veronika Micca, Hans P Müller, et al.
Brain : a Journal of Neurology|March 8, 2023
Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosisAlberto Catanese, Sandeep Rajkumar, Daniel Sommer, et al.
Translational Neurodegeneration|August 26, 2021
Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trialsSimon Witzel, Felix Frauhammer, Petra Steinacker, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2023
ALS is imprinted in the chromatin accessibility of blood cellsJulia K Kühlwein, Wolfgang P Ruf, Katharina Kandler, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatmentClaudia D Wurster, René Günther, Petra Steinacker, et al.
Neurological Research and Practice|December 15, 2022
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleAndré Maier, Matthias Boentert, Peter Reilich, et al.
Journal of Neurology|September 26, 2019
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersenClaudia D Wurster, Petra Steinacker, René Günther, et al.
Frontiers in Neurology|December 3, 2019
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With NusinersenClaudia D Wurster, Jan C Koch, Isabell Cordts, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Neurobiology of Aging|August 6, 2022
Fast versus slow disease progression in amyotrophic lateral sclerosis-clinical and genetic factors at the edges of the survival spectrumSimon Witzel, Matias Wagner, Chen Zhao, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 20, 2021
Phenotyping of the thoracic-onset variant of amyotrophic lateral sclerosisKatharina Kandler, Simon Witzel, Konstantin Eder, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2024
Primary lateral sclerosis: application and validation of the 2020 consensus diagnostic criteria in an expert opinion-based PLS cohortSimon Witzel, Veronika Micca, Hans P Müller, et al.
Brain : a Journal of Neurology|March 8, 2023
Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosisAlberto Catanese, Sandeep Rajkumar, Daniel Sommer, et al.
Translational Neurodegeneration|August 26, 2021
Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trialsSimon Witzel, Felix Frauhammer, Petra Steinacker, et al.
Cellular and Molecular Life Sciences : CMLS|April 24, 2023
ALS is imprinted in the chromatin accessibility of blood cellsJulia K Kühlwein, Wolfgang P Ruf, Katharina Kandler, et al.
Therapeutic Advances in Neurological Disorders|June 18, 2019
Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatmentClaudia D Wurster, René Günther, Petra Steinacker, et al.
Neurological Research and Practice|December 15, 2022
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleAndré Maier, Matthias Boentert, Peter Reilich, et al.
Journal of Neurology|September 26, 2019
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersenClaudia D Wurster, Petra Steinacker, René Günther, et al.
Frontiers in Neurology|December 3, 2019
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With NusinersenClaudia D Wurster, Jan C Koch, Isabell Cordts, et al.
Pageof 4